Patient ID | FISH (% of abnormal cells) | MLPA | Microarray-based genomic profiling | |
---|---|---|---|---|
 |  |  | Recurrent | Additional |
1 | Not done | Normal | Normal | Â |
2 | Not done | Loss 13q14 | Loss 13q14 | Â |
3 | Not done | Loss 13q14* | Loss 13q14* | Loss 6p |
Loss 17p13 | Loss 17p13 | CNLOH 13q | ||
4 | Not done | Loss 11q22 | Loss 11q22 | Gain 2p |
Loss 13q14 | Loss 13q14 | Loss 6p | ||
 |  | Loss 7q | ||
5 | Not done | Gain 12 | Gain 12 | Loss 1q |
6 | Not done 13q14 | Loss 13q14* | Loss 13q14* | Â |
 | Normal 11q22 |  |  |  |
 | Normal 17p13 |  |  |  |
7 | Normal 11q22 | Â | Â | Loss 1q |
 | Not done 12 | Gain 12 | Gain 12 |  |
 | Loss 17p13 (21%) | Loss 17p13 | Loss 17p13 |  |
8 | Not done | Loss 13q14 | Loss 13q14 | Â |
9 | Normal 11q22 | Loss 17p13 | Loss 17p13 | Gain 2p |
 | Loss 17p13 (21%) |  |  | Loss 6q |
 |  |  |  | Gain 17p11 |
 |  |  |  | Loss 20p |
10 | Gain 8 (28%) | Loss 17p13 | Loss 17p13 | Gain 8 |
 | Loss 17p13 (16%) |  |  | Gain 17q |
 | Normal 11q22 |  |  |  |
11 | Loss 11q22 (58%) | Loss 11q22 | Loss 11q22 | Gain Xq |
 | Normal CEP 12 | Gain 12q |  | Loss 3q |
 | Loss 13q14 (28%) | Loss 13q14 | Loss 13q14 | Loss 11p |
 | Normal 17p13 |  |  | Gain 12q |
12 | Not done | Loss 17p13 | Loss 17p13 | Gain 3q22 |
Loss 6q | ||||
Gain 19p | ||||
13 | Not done | Normal | Normal | Â |
14 | Not done | Gain 12 | Gain 12 | Â |
15 | Not done | Gain 12 | Gain 12 | Gain 18 |
Gain 19 | ||||
16 | Loss 13q14 (75%) | Loss 13q14 | Loss 13q14 | Â |
 | Normal 17p13 | Loss 17p13 (focal) | Loss 17p13 (focal) |  |
17 | Normal 11q22 | Not done | Gain 12 | CNLOH 2q |
Gain 12 (21%) | ||||
Normal 13q14 | ||||
Normal 17p13 | ||||
18 | Normal 11q22 | Not done | Loss 13q14 | Loss 1q |
Normal 12 | Â | Â | Loss 4p | |
Loss 13q14 (75%) | Â | Â | Loss 15q15 (MGA) | |
Normal 17p13 | Â | Â | Â | |
19 | Not done | Not done | Normal | Â |
20 | Normal 11q22 | Not done | ? loss 13q14 | CNLOH 6q |
Normal 12 | Â | Â | CNLOH 20q | |
Loss 13q14 (5%)* | Â | Â | Â | |
Normal 17p13 | ||||
21 | Normal 11q22 | Not done | Loss 13q14 | Loss 2p |
Normal 12 | Â | Â | Loss 8q | |
Loss 13q14 (60%) | Â | Â | Loss 10q24 | |
Normal 17p13 | Â | Â | CNLOH 17p | |
22 | Normal 11q22 | Not done | Normal | Â |
Normal 12 | Â | Â | Â | |
Normal 13q14 | Â | Â | Â | |
Normal 17p13 | Â | Â | Â | |
23 | Loss 11q22 (77%) | Not done | Loss 11q22 | Â |
Normal 12 | Â | Loss 13q14 | Â | |
Loss 13q14 (50%) | Â | Â | Â | |
Normal 17p13 | Â | Â | Â | |
24 | Normal 11q22 | Not done | Gain 12 | Gain 2q |
Gain 12 (21%) | Â | Â | Â | |
Normal 13q14 | Â | Â | Â | |
Normal 17p13 | Â | Â | Â | |
25 | Loss 11q22 (56%) | Not done | Loss 11q22 | Gain 2p |
Normal 12 | Â | Â | Loss 4q | |
Normal 13q14 | Â | Â | Loss 5q | |
Normal 17p13 | Â | Â | CNLOH 7pq | |
 |  |  | Loss 10p | |
Loss 11q | ||||
Loss 18q | ||||
Gain 21q | ||||
26 | Normal 11q22 | Not done | Gain 12 | Â |
Gain 12 (38%) | ||||
Normal 13q14 | ||||
Normal 17p13 | ||||
27 | Normal 11q22 | Not done | Loss 13q14* | Â |
Normal 12 | ||||
Loss 13q14 (86%)* | ||||
Normal 17p13 | ||||
28 | Normal 11q22 | Not done | Loss 13q14 | Loss 6q |
Normal 12 | Â | Loss 17p13 | Loss 15q | |
Loss 13q14 (33%) | Â | Â | Gain 17q | |
 | Loss 17p13 (39%) |  |  |  |